Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. MHAT Burgas (Burgas Main Hospital)

Source: Site record.

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

MBAL Burgas (Multiprofile Hospital for Active Treatment – Burgas) is the largest public multidisciplinary hospital in southeastern Bulgaria and a key tertiary care and referral center for the Black Sea region. With over 130 years of history and a capacity of around 680 beds, it provides comprehensive healthcare services across prevention, diagnosis, treatment, emergency care, and rehabilitation. The hospital operates as the primary 24/7 emergency center for Southeast Bulgaria, handling high patient volumes and complex regional cases, and serves more than 35,000 patients annually. It offers a broad spectrum of medical and surgical specialties supported by integrated diagnostic, laboratory, and intensive care infrastructure. MBAL Burgas is part of a wider healthcare network that includes collaboration with Life Hospital, strengthening its multidisciplinary capabilities and patient access.

Source: Trial-derived.
1Total Trials
Source: Trial-derived.
0Recruiting Trials
Source: Trial-derived.
0Active Trials
Source: Trial-derived.
0Completed Trials
Source: Trial-derived.
10Unique Conditions
Source: Trial-derived.
1Unique Sponsors

Conditions

Source: Trial-derived. CDI (1)Source: Trial-derived. C.Difficile Diarrhea (1)Source: Trial-derived. C. Diff Infection (1)Source: Trial-derived. Clostridioides Difficile Infection (1)Source: Trial-derived. Clostridioides Difficile Infection Recurrence (1)Source: Trial-derived. Clostridium Difficile (1)Source: Trial-derived. Clostridium Difficile Infection Recurrence (1)Source: Trial-derived. Clostridium Difficile Infections (1)

Sponsors

Source: Trial-derived. Vedanta Biosciences, Inc. (1)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot